Latest Articles

Publication Date
Going, going, gone: 23-story hotel in Miami demolished in seconds - newscentermaine.com

Going, going, gone: 23-story hotel in Miami demolished in seconds newscentermaine.com

Published: April 12, 2026, 4:57 p.m.
Cadonilimab Plus Chemotherapy Shows Strong Efficacy and Safety in Advanced or Recurrent Endometrial Cancer - OncLive

Cadonilimab Plus Chemotherapy Shows Strong Efficacy and Safety in Advanced or Recurrent Endometrial Cancer OncLive

Published: April 12, 2026, 2:35 p.m.
The NHS has a women problem - Spiked

The NHS has a women problem Spiked

Published: April 12, 2026, 9:55 a.m.
Endometrial NCOR1 deficiency contributes to implantation failure in endometriosis-associated infertility.

Endometriosis-associated infertility is a complex condition in which the presence of endometrial-like tissue disrupts implantation and early pregnancy. Epigenetic regulators are critical for implantation and decidualization, yet their contribution to …

Published: April 12, 2026, midnight
Spotify Premium: Get three months free - Mashable

Spotify Premium: Get three months free Mashable

Published: April 11, 2026, 8:13 p.m.
Abemaciclib Plus Letrozole Displays Durable Activity in Advanced/Recurrent Endometrioid Endometrial Carcinoma - OncLive

Abemaciclib Plus Letrozole Displays Durable Activity in Advanced/Recurrent Endometrioid Endometrial Carcinoma OncLive

Published: April 11, 2026, 4:04 p.m.
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer - The Manila Times

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer The Manila Times

Published: April 11, 2026, 11:01 a.m.
Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment - BioSpectrum Asia

Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment BioSpectrum Asia

Published: April 11, 2026, 7:52 a.m.
Natalie Githinji Moved to Tears by Fan’s Emotional Message on Her Digital Impact - Mpasho

Natalie Githinji Moved to Tears by Fan’s Emotional Message on Her Digital Impact Mpasho

Published: April 11, 2026, 6:46 a.m.
Reply of the authors: Trial emulation and clinical trials.

Published: April 11, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!